Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
TriMas Corp
TRS
$1.43B
| $6.25M | 0.01% |
301,417
+28,051
| +10% | +$615K |
|
1627
Global Net Lease
GNL
$1.95B
| $6.25M | 0.01% |
259,339
+35,419
| +16% | +$841K |
|
1628
Exponent
EXPO
$3.28B
| $6.24M | 0.01% |
209,444
+10,920
| +6% | +$318K |
|
1629
Interactive Brokers
IBKR
$41.1B
| $6.23M | 0.01% |
717,196
+60,968
| +9% | +$568K |
|
1630
Vanda Pharmaceuticals
VNDA
$304M
| $6.23M | 0.01% |
444,686
+10,383
| +2% | +$148K |
|
1631
US Foods
USFD
$23.9B
| $6.19M | 0.01% |
221,148
+120,862
| +121% | +$3.28M |
|
|
RESI
1632
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $6.19M | 0.01% |
405,718
+33,636
| +9% | +$438K |
|
1633
Lindsay Corp
LNN
$1.17B
| $6.19M | 0.01% |
70,198
+7,624
| +12% | +$597K |
|
|
AERI
1634
DELISTED
Aerie Pharmaceuticals
AERI
| $6.17M | 0.01% |
136,106
+1,388
| +1% | +$61.9K |
|
|
INFN
1635
DELISTED
Infinera Corporation Common Stock
INFN
| $6.13M | 0.01% |
598,766
+44,567
| +8% | +$447K |
|
1636
Sturm, Ruger & Co
RGR
$594M
| $6.12M | 0.01% |
114,313
+10,159
| +10% | +$522K |
|
1637
Thomson Reuters
TRI
$45.2B
| $6.12M | 0.01% |
122,013
-88,226
| -42% | -$4.51M |
|
1638
Supernus Pharmaceuticals
SUPN
$2.74B
| $6.11M | 0.01% |
195,279
+10,572
| +6% | +$283K |
|
1639
Ingles Markets
IMKTA
$1.62B
| $6.08M | 0.01% |
140,945
+12,221
| +9% | +$563K |
|
1640
Teekay
TK
$973M
| $6.08M | 0.01% |
663,869
+128,902
| +24% | +$1.25M |
|
1641
Sarepta Therapeutics
SRPT
$1.81B
| $6.07M | 0.01% |
205,187
+11,079
| +6% | +$343K |
|
1642
Griffon
GFF
$4.75B
| $6.07M | 0.01% |
246,125
+16,892
| +7% | +$421K |
|
1643
Primoris Services
PRIM
$4.35B
| $6.07M | 0.01% |
261,231
+21,860
| +9% | +$525K |
|
|
MTSC
1644
DELISTED
MTS Systems Corp
MTSC
| $6.04M | 0.01% |
109,744
+9,979
| +10% | +$560K |
|
1645
LivaNova
LIVN
$4.21B
| $6.04M | 0.01% |
123,251
+11,197
| +10% | +$545K |
|
1646
Halozyme
HALO
$12.2B
| $6.04M | 0.01% |
465,766
-4,726
| -1% | -$59.7K |
|
|
ARI
1647
Apollo Commercial Real Estate
ARI
$871M
| $6.04M | 0.01% |
320,791
+41,097
| +15% | +$730K |
|
1648
Aaon
AAON
$7.31B
| $6.02M | 0.01% |
255,522
+23,095
| +10% | +$530K |
|
1649
Materion
MTRN
$5.83B
| $5.99M | 0.01% |
178,605
+15,787
| +10% | +$579K |
|
1650
Smith & Wesson
SWBI
$636M
| $5.99M | 0.01% |
393,300
-316,332
| -45% | -$4.82M |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.